About Endocrinology
Editor-in-Chief, Associate Editors, and Editorial Board
Journal Facts for Endocrinology
Merger of Endocrinology and Molecular Endocrinology
Aims and Scope
Endocrinology, the flagship basic science journal of the Endocrine Society, welcomes the submission of original, foundational research investigating endocrine function in health and disease at all levels of biological organization, including molecular mechanistic studies of hormone-receptor interactions and hormone-regulated signaling events. Endocrinology encourages the submission of cross-disciplinary and integrative research in traditionally recognized fields of endocrinology as well as molecular studies in emerging areas of endocrine-related research, including mechanisms of signal transduction, the biochemistry and structural biology of receptors or other signaling molecules, epigenetic mechanisms of gene regulation and transcription, mitochondrial biochemistry, bioenergetics, cellular metabolism, and stem cell biology/tissue regeneration. Articles about clinical care and clinical case reports will not be considered.
Journal Facts for Endocrinology
Impact Factor 2023: 3.8
Frequency of publication: Monthly
ISSN (print journal): 0013-7227
ISSN (online): 1945-7170
Discovery Resources: CABI, Clarivate, EBSCO, IFIS, OCLC, ProQuest/ExLibris, PubMed, TDNet, and Yewno
Ownership: Owned by the Endocrine Society, published under contract with Oxford University Press
Our publishing partner, Oxford University Press (OUP), is a signatory of the San Francisco Declaration on Research Assessment (DORA), which is a world-wide initiative designed to improve the ways in which the outputs of scholarly research are evaluated. This includes reporting on a broader range of metrics. Find out more from OUP about the available metrics to assess both journals and individual articles here.
Contact
Endocrinology
Endocrine Society
2055 L Street NW, Suite 600
Washington, DC 20036
Phone: 202-971-3669
Patient Access
- Patients can request a copy of any article under access control. Please send the request to Member Services at [email protected]. Please include the year, issue, page number, and title of the article.
Obligations of Editors
- The Editor-in-Chief directs and supervises the policies of a journal and is responsible for maintaining its scientific and literary quality. The first obligation of an Editor-in-Chief and the journal’s Associate Editors is to make certain that all authors receive confidential, expert, critical, and unbiased reviews of their work in a timely fashion. The editors and members of the editor’s staff should not disclose any information about a manuscript submitted for review to anyone except the reviewers or authors or those working on their behalf.
- An editor may not take part in the editorial management of any report of the editor’s own research because that involves conflict of interest. An editor must also avoid conflict of interest in the editorial management of reports of research closely related to the editor’s own research.
- An editor may not use unpublished information of any kind from a submitted manuscript without written permission of the author.
- If an editor is presented with convincing evidence that the main substance or conclusions of a report published in an editor’s journal is erroneous or determined to be the result of misconduct, the editor should facilitate prompt publication of a report pointing out the error and, if possible, correcting it. The report may be written by all the authors. For circumstances in which this is not possible, or there is disagreement, the Editor-in-Chief may consider the report written by some of the authors, academic or institutional sponsor, editor, or the Society.
- The Endocrine Society appreciates the importance of assuring unbiased authorship of editorials, reviews, and other non-research features involving selection of evidence to be discussed and perspectives to be presented. Consequently, special care is taken in choosing authors for such articles to assure their views are balanced and unencumbered, and that the Society’s policies on disclosure of conflicts of interest are implemented.
- The Endocrine Society journals will refrain from publishing articles addressing political issues that are outside of either research funding or health care delivery. See the Statement of Principle for more information.
Advertising
- All Endocrine Society Journals contain advertisements but advertising is not allowed to influence editorial decisions. Readers will be able to readily distinguish between editorial material and advertising. The juxtaposition of advertisements promoting specific products and scientific articles discussing such products is, as far as possible, avoided.
- The Endocrine Society and the editors do not provide unpublished advance information about journal content for forthcoming issues to agencies involved in soliciting advertisements or companies purchasing advertising space.
- The appearance of any advertisement does not imply warranty, endorsement, or approval of the products or services or of their effectiveness, quality, or safety by the Endocrine Society.
- The Society has the prerogative to reject any advertisement it deems inappropriate. It accepts advertisements only if the advertiser represents and warrants that its advertisement does not violate any applicable federal, state, or local laws.
Merger of Endocrinology and Molecular Endocrinology
- Endocrinology merged with the journal Molecular Endocrinology in November 2016.
